translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
UNITED STATES: Merck Recalls Hepatitis B Vaccine
By David Sell
July 8, 2013 External Web Site Policy, (07.05.2013)

On July 3, pharmaceutical manufacturer Merck & Co. announced a voluntary recall of 27,020 vials of Recombivax HB, an adult formulation of hepatitis B vaccine. Merck feared some vaccine vials in lot J001183 cracked during the packing process at the company’s West Point, Montgomery County, Pa., plant. The company could not guarantee the vaccine’s sterility if the vials were cracked. Merck Spokesperson Lainie Keller reported the company had corrected the issue and instituted preventive measures. The US Food and Drug Administration Web site also posted notice of the recall. Merck distributed lot J001183 nationwide from March 12 to May 2, but was unable to state which physicians, pharmacies, or wholesalers received the potentially damaged vials. Keller stated that Merck had sufficient inventory on hand to replace the recalled product.